Select Page

WSMD 2025 | Posters

Use the buttons below to navigate the page.  Each window will reveal a link to a PDF of the respective poster in a new tab.

General
Research
Top

General Posters

P1- Sex Differences in Clinical Pharmacology

P1-Sex Differences in Clinical Pharmacology

P2- He and she in clinical pharmacology

P2-He and she in clinical pharmacology

P3- Hormones & Healing: The Gender Impact on Prednisone

P3-HORMONES & HEALING_ THE GENDER IMPACT ON PREDNISONE

P4- Assessing Gender Differences in Neuropathic Pain Management: Findings from a Real Life Clinical Cross Sectional Observational Study

P4-Assessing Gender Differences in Neuropathic Pain Management_ Findings from a Real_Life Clinical Cross Sectional Observational Study

P5- New Male Contraceptive Method

P5- New Male Contraceptive Method

P6- Gender Differences in Clinical Pharmacology

P6-Gender Differences in Clinical Pharmacology

P7- Blowing up Pharmacology

P7-Blowing up Pharmacology

P8- Poor Sex-Specific Reporting of Results from Phase 3 Studies of New Drugs Approved in Europe between 2017-2021

P8-Poor Sex-Specific Reporting of Results from Phase 3 Studies of New Drugs Approved in Europe between 2017-2021

P9- One pill fits for all approach has to stop

P9-One pill fits for all approach has to stop

P10- How Sex-Based Pharmacology Leads to Safer, Smarter Treatment

P10-How Sex-Based Pharmacology Leads to Safer, Smarter Treatment

P11-Advancements in Pediatric Physiologically-Based Pharmacokinetic (PBPK) Modeling of Drugs in Lactation for Guiding Neonatal Exposure Risk Assessment

P11-ADVANCEMENTS IN PEDIATRIC PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODELING OF DRUGS IN LACTATION FOR GUIDING NEONATAL EXPOSURE RISK ASSESSMENT

P12- A Lack of Diversity of Patient Representation in Medicine Development

P-12A Lack of Diversity of Patient Representation in Medicine Development

Sex-Gender Differences in Clinical Pharmacology

Sex-Gender Differences in Clinical Pharmacology

General
Research
Top

Research Posters

P13- The Influence of Gender on the severity of Adverse Drug Reactions among in-ward patients : An Active surveillance in the National Hospital Galle.

P13-The Influence of Gender on the severity of Adverse Drug Reactions among in-ward patients. an Active surveillance in the National Hospital Galle.

P14- Differences in Germline Mutations Affecting Platinum Chemotherapy Sensitivity Between Male and Female in Non-Small Cell Lung Cancer Patients

P14-Differences in Germline Mutations Affecting Platinum Chemotherapy Sensitivity Between Male and Female in Non-Small Cell Lung Cancer Patients

P15- Sex Differences in the Efficacy and Side Effects of Lamotrigine and Levetiracetam

P15-Sex Differences in the Efficacy and Side Effects of Lamotrigine and Levetiracetam

P16- Sex Differences in Imatinib and Sunitinib Exposure_ The Role of Pharmacogenetics and Therapeutic Drug Monitoring

P16-Sex Differences in Imatinib and Sunitinib Exposure_ The Role of Pharmacogenetics and Therapeutic Drug Monitoring

P17- Sex Influence on Juvenile Stress

P17-Sex Influence on Juvenile Stress

P18- Sex Differences in Drug-Induced Liver Injury: Same Pills, Different Thrills

P18- Sex Differences in Drug-Induced Liver Injury_ Same Pills, Different Thrills_

P19- Exploring the cardiometabolic burden amongst antipsychotic users - Real-world evidence from Australia

P19-Exploring the cardiometabolic burden amongst antipsychotic users – Real-world evidence from Australia

P20- A Gender- and Sex-sensitive primary care intervention for patients with Chronic non-cancer pain receiving long-term Opioid therapy (GESCO)

P20- A GEnder- and Sex-sensitive primary care intervention for patients with Chronic non-cancer pain receiving long-term Opioid therapy (GESCO)

P21- Sex differences in optimal medical therapy following invasive angiography for coronary artery disease

P21- Sex differences in optimal medical therapy following invasive angiography for coronary artery disease_

P22- Sex-Specific Transcriptional Dynamics of MYH6 and MYH7 in Human Heart: Insights from Large-Scale Cohort Studies

P22- Sex-Specific Transcriptional Dynamics of MYH6 and MYH7 in Human Heart_ Insights from Large-Scale Cohort Studies_

P23- Sex Differences in Clinical Pharmacology

P23-Sex Differences in Clinical Pharmacology

P24- Does the Patient's Gender Play a Role in the Prescription of New Drugs

P24-DOES THE PATIENT’S GENDER PLAY A ROLE IN THE PRESCRIPTION OF NEW DRUGS

P25- Determining Critical Physiological and Drug-Specific Parameters for Enhancing a Physiologically-Based Pharmacokinetics Model for the Female Reproductive Tract

P25-DETERMINING CRITICAL PHYSIOLOGICAL AND DRUG SPECIFIC PARAMETERS FOR ENHANCING A PHYSIOLOGICALLY-BASED PHARMACOKINETICS MODEL FOR THE FEMALE REPRODUCTIVE TRACT

General
Research
Top